{"title":"Invasive aspergillosis due to cryptic Aspergillus species: A prospective study from a single centre in India","authors":"R. Sruti Janani, Immaculata Xess, Bimal Kumar Das, Saumya Cs, Tamanna Bordoloi, Mragnayani Pandey, Jaweed Ahmed, Gagandeep Singh","doi":"10.1016/j.ijmmb.2024.100708","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p><u>& objective</u>: The existence of visually identical cryptic <em>Aspergillus</em> species that can be distinguished only by molecular techniques is becoming more widely acknowledged. For the majority of antifungal drugs, these are known to exhibit a greater minimal inhibitory concentration in vitro. For the purpose of receiving the proper care, it is crucial to identify these species at right time. Our aim in this work is to identify and describe the <em>Aspergillus</em> species that are cryptic from all of the clinical samples.</p></div><div><h3>Methods</h3><p>Routine samples from inpatients and outpatients received in department of Microbiology, All India Institute of Medical Sciences, New Delhi, showing growth of <em>Aspergillus</em> species were included in this study. Phenotypic and Matrix Assisted Laser Desorption Ionisation - Time of Flight identified isolates were analysed for cryptic species, by PCR and ITS/<em>ß</em> – tubulin sequencing. In accordance with CLSI recommendations, antifungal susceptibility testing was conducted using micro broth dilution.</p></div><div><h3>Results</h3><p>Of the 94 isolates, 54 <em>A. fumigatus</em>, 34 <em>A. flavus</em>, 3 <em>A. nidulans</em>, 2 <em>A. terreus,</em> and 1 <em>A. niger</em> were morphologically identified. MALDI-TOF misidentified 2 <em>A. nidulans</em> isolates and 1 <em>A, stellatus</em> isolate. The <em>ß</em> – tubulin sequence analysis revealed that 2 isolates (2.08 %) were cryptic, one was <em>A. stellatus</em> and another one was <em>A. tubingensis</em>.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Medical Microbiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S025508572400183X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
& objective: The existence of visually identical cryptic Aspergillus species that can be distinguished only by molecular techniques is becoming more widely acknowledged. For the majority of antifungal drugs, these are known to exhibit a greater minimal inhibitory concentration in vitro. For the purpose of receiving the proper care, it is crucial to identify these species at right time. Our aim in this work is to identify and describe the Aspergillus species that are cryptic from all of the clinical samples.
Methods
Routine samples from inpatients and outpatients received in department of Microbiology, All India Institute of Medical Sciences, New Delhi, showing growth of Aspergillus species were included in this study. Phenotypic and Matrix Assisted Laser Desorption Ionisation - Time of Flight identified isolates were analysed for cryptic species, by PCR and ITS/ß – tubulin sequencing. In accordance with CLSI recommendations, antifungal susceptibility testing was conducted using micro broth dilution.
Results
Of the 94 isolates, 54 A. fumigatus, 34 A. flavus, 3 A. nidulans, 2 A. terreus, and 1 A. niger were morphologically identified. MALDI-TOF misidentified 2 A. nidulans isolates and 1 A, stellatus isolate. The ß – tubulin sequence analysis revealed that 2 isolates (2.08 %) were cryptic, one was A. stellatus and another one was A. tubingensis.
期刊介绍:
Manuscripts of high standard in the form of original research, multicentric studies, meta analysis, are accepted. Current reports can be submitted as brief communications. Case reports must include review of current literature, clinical details, outcome and follow up. Letters to the editor must be a comment on or pertain to a manuscript already published in the IJMM or in relation to preliminary communication of a larger study.
Review articles, Special Articles or Guest Editorials are accepted on invitation.